| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in AIM over the last quarter tilts toward buying: insiders added a net 125,825 shares worth roughly $24K. In the past 30 days, 1 insider bought and 0 sold. Purchases have clustered in the most recent filings.
Equels Thomas K (CEO &President) stands out among recent buyers, now holding an estimated $30K in AIM. A senior officer buying with their own money is generally read as a stronger signal than routine insider selling.
Classified under Biotechnology (Health Care sector), AIM's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 189.7K | $30.4K | +62.9K | |
| Dir | 28.4K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 15, 2024 | Equels Thomas K | CEO &President | Buy | 75,758 | $0.33 | $25,000.14 | +11.8% | +24.2% | -63.6% | |
| Nov 27, 2023 | Equels Thomas K | CEO &President | Buy | 33,861 | $0.44 | $15,000.42 | +5.6% | -4.7% | -46.5% | |
| Sep 29, 2023 | Equels Thomas K | CEO &President | Buy | 22,676 | $0.44 | $10,000.12 | +3.9% | +4.3% | -39.1% | |
| Aug 25, 2023 | Equels Thomas K | CEO &President | Buy | 8,222 | $0.67 | $5,500.52 | +1.4% | -35.8% | -44.8% | |
| Aug 24, 2023 | Equels Thomas K | CEO &President | Buy | 14,993 | $0.67 | $10,000.33 | +2.7% | -35.8% | -44.8% | |
| Jul 17, 2023 | Equels Thomas K | CEO &President | Buy | 16,950 | $0.59 | $10,000.50 | +3.1% | -25.8% | -35.5% | |
| Jan 3, 2023 | Equels Thomas K | CEO &President | Buy | 161,291 | $0.31 | $50,000.21 | +42.1% | +31.3% | +50.0% | |
| Jan 3, 2023 | Appelrouth Stewart | Director | Buy | 80,646 | $0.31 | $25,000.26 | +59.1% | +31.3% | +50.0% | |
| Jan 3, 2023 | Rodino Peter W III | COO, Secretary, Gen. Counsel | Buy | 80,646 | $0.31 | $25,000.26 | +127.6% | +31.3% | +50.0% | |
| Jul 16, 2021 | Equels Thomas K. | CEO &President | Buy | 15,625 | $1.92 | $30,000.00 | +7.5% | -2.0% | -61.6% |